ARS Pharmaceuticals
SPRY
$9.03
Share price
-0.77%
Change (1 day)
8.93%
Change (1 year)
Categories
ARS Pharmaceuticals (SPRY) - Cash on Hand
Cash on Hand as of December 2023 : $0.22 B
According to ARS Pharmaceuticals's latest financial reports the company has $0.22 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
ARS Pharmaceuticals - Cash on Hand chart (from 2021 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.27 B | 356.82% |
| 2021-12-31 | $60.06 M | 144.95% |
| 2020-12-31 | $24.52 M |